Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

May/June 1993

Volume 2, Issue 3

Pages fmi–fmi, 173–238

  1. Masthead

    1. Top of page
    2. Masthead
    3. Editorials
    4. Letter to the Editor
    5. Methodology
    6. Original Report
    7. Current Awareness
    1. Masthead (page fmi)

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020301

  2. Editorials

    1. Top of page
    2. Masthead
    3. Editorials
    4. Letter to the Editor
    5. Methodology
    6. Original Report
    7. Current Awareness
    1. Editorial (pages 173–174)

      R. D. Mann

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020302

  3. Letter to the Editor

    1. Top of page
    2. Masthead
    3. Editorials
    4. Letter to the Editor
    5. Methodology
    6. Original Report
    7. Current Awareness
    1. Towards a new adverse event dictionary (pages 175–176)

      Professor Ralph Edwards, Ray Herman, Michael Dreis and Christopher Raynor

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020303

  4. Methodology

    1. Top of page
    2. Masthead
    3. Editorials
    4. Letter to the Editor
    5. Methodology
    6. Original Report
    7. Current Awareness
    1. Proposed improvement to the WHO adverse reaction terminology (WHO-ART) (pages 177–184)

      I. Ralph Edwards, Gaby Danan, Cecilia Biriell and Christian Benichou

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020304

  5. Original Report

    1. Top of page
    2. Masthead
    3. Editorials
    4. Letter to the Editor
    5. Methodology
    6. Original Report
    7. Current Awareness
    1. Auditing drug therapy by peer review — the German experience (pages 195–200)

      Liselotte von Ferber

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020307

    2. Delay and completeness of cancer registration in a post-marketing surveillance study of cimetidine (pages 201–203)

      T. Lucas, J. Beresford and M. Vessey

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020308

    3. The safety and tolerability of the β2-agonist salbutamol in an event monitoring study of an oral controlled release formulation (‘Volmax’) (pages 205–216)

      Diana E. H. Barkley, Dr. Darrall L. Higson and Kenneth R. Paterson

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020309

    4. Effect of federally mandated education policies on prescribing of isotretinoin to women of childbearing age (pages 217–221)

      Susan R. Heckbert, Glaudine Mtshali and Richard Platt

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020310

  6. Current Awareness

    1. Top of page
    2. Masthead
    3. Editorials
    4. Letter to the Editor
    5. Methodology
    6. Original Report
    7. Current Awareness
    1. Pharmacoepidemiology and drug safety (pages 223–238)

      Article first published online: 12 JAN 2006 | DOI: 10.1002/pds.2630020311

SEARCH

SEARCH BY CITATION